MediFind
Condition

Autosomal Recessive Hypotrichosis

Condition 101

What is the definition of Autosomal Recessive Hypotrichosis?

Autosomal recessive hypotrichosis is a condition that affects hair growth. People with this condition have sparse hair (hypotrichosis) on the scalp beginning in infancy. This hair is usually coarse, dry, and tightly curled (often described as woolly hair). Scalp hair may also be lighter in color than expected and is fragile and easily broken. Affected individuals often cannot grow hair longer than a few inches. The eyebrows, eyelashes, and other body hair may be sparse as well. Over time, the hair problems can remain stable or progress to complete scalp hair loss (alopecia) and a decrease in body hair.Rarely, people with autosomal recessive hypotrichosis have skin problems affecting areas with sparse hair, such as redness (erythema), itchiness (pruritus), or missing patches of skin (erosions) on the scalp. In areas of poor hair growth, they may also develop bumps called hyperkeratotic follicular papules that develop around hair follicles, which are specialized structures in the skin where hair growth occurs.

What are the causes for Autosomal Recessive Hypotrichosis?

Autosomal recessive hypotrichosis can be caused by mutations in the LIPH, LPAR6, or DSG4 gene. These genes provide instructions for making proteins that are involved in the growth and division (proliferation) and maturation (differentiation) of cells within hair follicles. These cell processes are important for the normal development of hair follicles and for hair growth; as the cells in the hair follicle divide, the hair strand (shaft) is pushed upward and extends beyond the skin, causing the hair to grow. The proteins produced from the LIPH, LPAR6, and DSG4 genes are also found in the outermost layer of skin (the epidermis) and glands in the skin that produce a substance that protects the skin and hair (sebaceous glands).Mutations in the LIPH, LPAR6, or DSG4 gene result in the production of abnormal proteins that cannot aid in the development of hair follicles. As a result, hair follicles are structurally abnormal and often underdeveloped. Irregular hair follicles alter the structure and growth of hair shafts, leading to woolly, fragile hair that is easily broken. A lack of these proteins in the epidermis likely contributes to the skin problems sometimes seen in affected individuals.In some areas of the body, other proteins can compensate for the function of the missing protein, so not all areas with hair are affected and not all individuals have skin problems.

How prevalent is Autosomal Recessive Hypotrichosis?

The worldwide prevalence of autosomal recessive hypotrichosis is unknown. In Japan, the condition is estimated to affect 1 in 10,000 individuals.

Is Autosomal Recessive Hypotrichosis an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Top Global Doctors

RP
Elite
Ralf Paus
Manchester, ENG, GB
RB
Elite
Regina C. Betz
Bonn, NW, DE
WL
Elite
Won-soo S. Lee
Wondu, 46, KR

Latest Research

Latest Advance
Study
  • Condition: COVID-19
  • Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
  • Treatment Used: Hydroxychloroquine plus Atazanavir/ritonavir
  • Number of Patients: 213
  • Published —
In this study, researchers evaluated the safety and effectiveness of hydroxychloroquine plus atazanavir/ritonavir for the treatment of moderate and severe COVID-19.
Latest Advance
Study
  • Condition: Alopecia Totalis (AT)
  • Journal: Ugeskrift for laeger
  • Treatment Used: Tofacitinib
  • Number of Patients: 1
  • Published —
This study evaluated the treatment of tofacitinib in a patient with alopecia totalis (loss of all skull and facial hair; AT).
Latest Advance
Study
  • Condition: Androgenetic Alopecia
  • Journal: BioMed research international
  • Treatment Used: Botulinum Toxin Type A
  • Number of Patients: 63
  • Published —
The purpose of the study was to investigate the effectiveness and safety of botulinum toxin type A in patients with androgenetic alopecia.
Latest Advance
Study
  • Condition: Metastatic Colon Adenocarcinoma
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: Oxaliplatin, Fluorouracil, and Folinic Acid Combined with Cetuximab
  • Number of Patients: 1
  • Published —
This case report discusses a patient with metastatic colon adenocarcinoma (tumor in the glands of the large intestine that has spread to other organs) who was treated with oxaliplatin, fluorouracil, and folinic acid combined with cetuximab.

Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 381
  • Start Date: July 2, 2020
Anti-Androgen Treatment for COVID-19
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 40
  • Start Date: July 1, 2020
Using Indirect Cold Atmospheric Pressure Plasma (Plasma Activate Liquid) for the Treatment of Hair Loss
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 200
  • Start Date: June 15, 2020
HairDx Analytical Validation Study